NOVORAPID FLEXPENS

NovoRapid 100IU/ml FlexPen is indicated for the management of blood glucose levels in individuals diagnosed with type 1 or type 2 diabetes mellitus. This insulin formulation acts rapidly to decrease glucose concentrations following meal consumption, thereby helping to mitigate the risk of serious diabetes-related complications. Typically, NovoRapid is used in conjunction with a long-acting insulin or other anti-diabetic medications, as determined by a healthcare professional. Proper administration techniques will be instructed by your healthcare provider, emphasizing the importance of subcutaneous injection. For optimal effectiveness, it is recommended to administer this medication at the onset of a meal or within 20 minutes after starting to eat. Regular monitoring of blood sugar levels is crucial; you should keep a record and discuss these figures with your doctor to fine-tune your dosage appropriately. It is critical to avoid using this medication if you are experiencing hypoglycemia. Prior to beginning treatment, inform your healthcare provider about any history of kidney, liver, or cardiac issues. Pregnant or nursing individuals should also seek medical advice regarding potential adjustments in dosage. It is imperative not to discontinue this medication unless directed by a healthcare professional, as it is part of a comprehensive diabetes management plan that should include a balanced diet, physical activity, and weight management as necessary.